COX-2 is expressed in human pulmonary, colonic, and mammary tumors
Data up to Jan 2025
Total Citations Per Year
Abstract
References (51)
TNM Classification of Malignant Tumors
1998 • 5,989 citations
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
1994 • 2,553 citations
The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
2000 • 2,505 citations
Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
1995 • 2,308 citations
Expression of cyclooxygenase-1 and -2 in human colorectal cancer.
1995 • 1,135 citations
Aspirin and the Risk of Colorectal Cancer in Women
1995 • 1,116 citations
Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.
1998 • 933 citations
Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas.
1998 • 825 citations
Expression of cyclooxygenase-2 in human lung carcinoma.
1998 • 729 citations
Regulation of the immune response by prostaglandins
1983 • 717 citations
Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines.
1993 • 710 citations
Aspirin and the potential role of prostaglandins in colon cancer.
1992 • 694 citations
Expression of Cyclooxygenase-1 and Cyclooxygenase-2 in Human Breast Cancer
1998 • 665 citations
Incidence of and Treatment for Ductal Carcinoma In Situ of the Breast
1996 • 600 citations
Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin‐1: a potential mechanism for inflammatory angiogenesis
1995 • 565 citations
Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production.
1998 • 498 citations
Transcriptional Regulation of Human Prostaglandin-endoperoxide Synthase-2 Gene by Lipopolysaccharide and Phorbol Ester in Vascular Endothelial Cells
1995 • 487 citations
TNM Classification of Malignant Tumors.5th ed
1998 • 455 citations
Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells.
1996 • 426 citations
Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis.
1996 • 421 citations
Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis
1999 • 413 citations
Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent.
1995 • 400 citations
Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester.
1994 • 377 citations
Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels.
1997 • 362 citations
PGE2 and Angiogenesis
1983 • 341 citations
Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition
1999 • 334 citations
Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX‐2 inhibitor
1997 • 326 citations
Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development.
1987 • 305 citations
Aspirin and reduced risk of esophageal carcinoma
1995 • 290 citations
A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors
1996 • 281 citations
Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer
1993 • 276 citations
Cyclooxygenase-2 gene expression in human breast cancer
1997 • 274 citations
Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines.
1996 • 244 citations
Regulation of cyclooxygenase-2 expression in aortic smooth muscle cells.
1994 • 154 citations
The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis
1998 • 142 citations
Potential utility of COX-2 inhibitors in chemoprevention and chemotherapy
1999 • 123 citations
Ackerman's Surgical Pathology
1997 • 119 citations
Dominance of cyclooxygenase-2 in the regulation of pancreatic islet prostaglandin synthesis.
1998 • 117 citations
Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats.
1996 • 117 citations
Antitumoral Activity of Indomethacin on Experimental Esophageal Tumors
1984 • 88 citations
Inhibition of lung tumourigenesis by sulindac: comparison of two experimental protocols
1997 • 87 citations
Effects of NSAIDs on Proliferation of Gastric Cancer Cells In Vitro: Possible Implication of Cyclooxygenase-2 in Cancer Development
1998 • 82 citations
Inhibition of mammary carcinogenesis by flurbiprofen, a non-steroidal antiinflammatory agent
1983 • 77 citations
Further studies on the therapeutic effect of indomethacin on esophageal tumors
1986 • 71 citations
Increased Expression of Cyclooxygenase-2 to -1 in Human Colorectal Cancers and Adenomas, but not in Hyperplastic Polyps
1998 • 69 citations
Delay in hamster buccal pouch carcinogenesis by aspirin and indomethacin
1982 • 62 citations
The role of COX-2 in intestinal cancer
1999 • 59 citations
Why is cyclooxygenase‐2 expressed in neuroendocrine cells of the human alimentary tract?
1997 • 20 citations
Section Review Oncologic, Endocrine & Metabolic: Angiogenesis inhibition as a drug target for disease: an update
1996 • 17 citations
Heterogeneous Distribution of COX-2 Over-Expression in Human Colon Carcinoma Cells
1997 • 4 citations
Deleted Work
1955 • 0 citations
Cited By (0)
No citing papers found in database